Role of HIV-1 Tat in the pathogenesis of AIDS-associated Kaposi's sarcoma. 1994

L Buonaguro, and F M Buonaguro, and M L Tornesello, and E Beth-Giraldo, and E Del Gaudio, and B Ensoli, and G Giraldo
Division of Viral Oncology, Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012514 Sarcoma, Kaposi A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause. Kaposi Sarcoma,Kaposi's Sarcoma,Multiple Idiopathic Pigmented Hemangiosarcoma,Kaposis Sarcoma,Sarcoma, Kaposi's
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015696 Gene Products, tat Trans-acting transcription factors produced by retroviruses such as HIV. They are nuclear proteins whose expression is required for viral replication. The tat protein stimulates LONG TERMINAL REPEAT-driven RNA synthesis for both viral regulatory and viral structural proteins. Tat stands for trans-activation of transcription. tat Gene Products,tat Protein,Gene Product, tat,tat Gene Product
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D054322 tat Gene Products, Human Immunodeficiency Virus Proteins encoded by the TAT GENES of the HUMAN IMMUNODEFICIENCY VIRUS. HIV Transacting Transcription Protein,HIV tat Protein,Trans-Acting Transcription Factor, HIV,Trans Acting Transcription Factor, HIV,tat Protein, HIV

Related Publications

L Buonaguro, and F M Buonaguro, and M L Tornesello, and E Beth-Giraldo, and E Del Gaudio, and B Ensoli, and G Giraldo
March 1988, Lymphology,
L Buonaguro, and F M Buonaguro, and M L Tornesello, and E Beth-Giraldo, and E Del Gaudio, and B Ensoli, and G Giraldo
April 1991, Hematology/oncology clinics of North America,
L Buonaguro, and F M Buonaguro, and M L Tornesello, and E Beth-Giraldo, and E Del Gaudio, and B Ensoli, and G Giraldo
April 2002, Clinical microbiology reviews,
L Buonaguro, and F M Buonaguro, and M L Tornesello, and E Beth-Giraldo, and E Del Gaudio, and B Ensoli, and G Giraldo
January 1998, Journal of the National Cancer Institute. Monographs,
L Buonaguro, and F M Buonaguro, and M L Tornesello, and E Beth-Giraldo, and E Del Gaudio, and B Ensoli, and G Giraldo
February 2000, Virology,
L Buonaguro, and F M Buonaguro, and M L Tornesello, and E Beth-Giraldo, and E Del Gaudio, and B Ensoli, and G Giraldo
January 2016, Sarcoma,
L Buonaguro, and F M Buonaguro, and M L Tornesello, and E Beth-Giraldo, and E Del Gaudio, and B Ensoli, and G Giraldo
April 1988, AIDS (London, England),
L Buonaguro, and F M Buonaguro, and M L Tornesello, and E Beth-Giraldo, and E Del Gaudio, and B Ensoli, and G Giraldo
September 1993, Current opinion in oncology,
L Buonaguro, and F M Buonaguro, and M L Tornesello, and E Beth-Giraldo, and E Del Gaudio, and B Ensoli, and G Giraldo
March 1996, Oncology (Williston Park, N.Y.),
L Buonaguro, and F M Buonaguro, and M L Tornesello, and E Beth-Giraldo, and E Del Gaudio, and B Ensoli, and G Giraldo
May 1990, Nature,
Copied contents to your clipboard!